Shuttle Pharmaceuticals (SHPH) News
NASDAQ: SHPHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SHPH news summary
We found 3 recent headlines mentioning Shuttle Pharmaceuticals (SHPH): 1 in the past week and 2 in the past 30 days, most often from Nasdaq. SHPH is making an outsized move today, down 10.51% at $3.49, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Shuttle Pharmaceuticals Holdings, Inc. Amends Securities Purchase Agreement and Issues Milestone Pre-Funded Warrants", was published by Nasdaq on Nov 19, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Shuttle Pharmaceuticals headlines
- Shuttle Pharmaceuticals Holdings, Inc. Amends Securities Purchase Agreement and Issues Milestone Pre-Funded WarrantsOn November 13, 2026, Shuttle Pharmaceuticals Holdings, Inc. entered into an Amendment to Securities Purchase Agreement with certain investors constituting at least 67% of the purchasers under the…NasdaqSHPH, BIO.B
- Shuttle Pharmaceuticals Holdings, Inc. Engages Bush & Associates CPA LLC on November 2, 2026On November 2, 2026, Shuttle Pharmaceuticals Holdings, Inc. engaged Bush & Associates CPA LLC as its new independent registered public accounting firm, upon the full execution of an engagement letter…Nasdaq
- Shuttle Pharmaceuticals Holdings, Inc. Dismisses Forvis Mazars, LLPOn October 16, 2026, the Audit Committee of the Board of Directors of Shuttle Pharmaceuticals Holdings, Inc., and the full Board, approved the dismissal of Forvis Mazars, LLP as the Company’s…Nasdaq